Lyme disease in Wisconsin: epidemiologic, clinical, serologic, and entomologic findings. by Davis, J. P. et al.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 57 (1984), 685-696
Lyme Disease in Wisconsin: Epidemiologic, Clinical,
Serologic, and Entomologic Findings
JEFFREY P. DAVIS, M.D., WENDY L. SCHELL, M.S.,
TERRY E. AMUNDSON, Ph.D., MARVIN S. GODSEY, Jr., B.S.,
ANDREW SPIELMAN, Ph.D., WILLY BURGDORFER, Ph.D.,
ALAN G. BARBOUR, M.D., MARTIN LaVENTURE, M.P.H.,
AND RICHARD A. KASLOW, M.D.
Bureau of Community Health and Prevention, Wisconsin Division ofHealth;
Departments ofPediatrics and Preventive Medicine, University of Wisconsin
Clinical Sciences Center; Bureau of Wildlife Management, Wisconsin Department
ofNatural Resources, Madison, Wisconsin; School ofPublic Health, Harvard
University, Boston, Massachusetts; Rocky Mountain Laboratories, Hamilton,
Montana; National Institutes ofHealth, Bethesda, Maryland
Received December 19, 1983
In 1980-82, 80 individuals (71 Wisconsin residents) had confirmed Lyme disease (LD-c)
reported; 39 additional patients had probable or possible LD. All cases of LD-c occurred dur-
ing May-November; 73 percent occurred during June-July; 54 (68 percent) occurred in males.
The mean age was 38.7 years (range, 7-77 years). Among LD-c patients, likely exposure to the
presumed vector Ixodesdammini(ID) occurred in 22 different Wisconsin counties. Antibodies
to the ID spirochete that causes LD occurred in 33 of49 LD-c cases versus0of 18 in ill controls
(p <.001) and in 13 of26 LD-c cases treated with penicillin ortetracycline versus 16 of 19 LD-c
cases not treated. Early antibiotic therapy appears to blunt the antibody response to the ID
spirochete. Regional tick surveys conducted in Wisconsin during each November in 1979-82
have demonstrated regions of greater density of ID. Utilizing comparable tick collection in
these surveys, increases were noted in the percentage of deer with ID from 24 percent (31/128)
in 1979 to 38 percent (58/152) in 1981, in the standardized mean value of ID/deer from 1.0 in
1979 to 2.2 in 1981, in the percentage of ID ofthe total ticks collected from 13 percent in 1979
to 71 percent in 1981, or in the ratio of ID to Dermacentoralbipictusticks from 0.14 in 1979 to
2.44 in 1981. However, a reduction in the density of ID/deer was noted generally throughout
Wisconsin in 1982 when compared to 1981. LD is widespread in Wisconsin, with ecologic and
clinical features similar to those occurring along the eastern seaboard.
INTRODUCTION
Lyme disease (LD) is an immune-mediated inflammatory illness characterized by
a distinctive primary skin lesion, erythema chronicum migrans (ECM), and in many
cases concomitant or subsequent development of cardiac, neurologic, or arthritic
complications [1,2]. It is caused by a tetracycline-, penicillin-, and erythromycin-
sensitive spirochete [3-5] transmitted by ticks of the genus Ixodes [3-6], although
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All rights of reproduction in any form reserved.other vectors may be involved. Since the early descriptions of Lyme disease in Con-
necticut in 1976 [1], LD has been recognized in at least 16 additional states in the
East, the upper Midwest, and the West [7,8].
The first published report ofECM in the Uni-ted States involved apatient who had
been exposed to ticks in Taylor County, Wisconsin, in 1968 while grouse hunting
[9]. The patient also had additional manifestations of LD. Subsequently, a descrip-
tion of the full complex ofsigns and symptoms of LD occurring in three patients in
Wisconsin in 1978 [10] prompted a more intensive search. Since autumn 1979, the
Wisconsin Division of Health (DOH) has been investigating suspect cases of LD to
delineate the clinical illness and areas ofLD risk in the state [11-13]. The purpose of
this report is to present clinical, epidemiologic, serologic, and entomologic observa-
tions on LD in Wisconsin in the period 1980 to 1982.
MATERIALS AND METHODS
Surveillancefor Lyme Disease in Humans
Reports of LD for this study were obtained through passive surveillance tech-
niques stimulated by statewide mailings to physicians in each of the years 1980 to
1982. The mailings described the illness, and requested physicians to report suspect
cases to the DOH and to submit paired serum specimens to the Wisconsin State
Laboratory of Hygiene (SLH). Once a report was received or a request for LD-
related laboratory studies at the SLH was made, the patient's physician was asked to
complete a comprehensive case report form and initial and follow-up patient
telephone interviews were completed by DOH personnel. The following information
was requested: age, sex, race, county ofresidence, history of exposures to ticks and
tick bites including location onthe body, county oftick exposure or tick bites, travel
history in the three weeks prior to illness onset; ECM onset and duration, location
and number of ECM lesions, diameter of largest lesion, and other descriptive
features of the rash; onset and duration of fever, headache, stiff neck, malaise,
myalgia, nausea, vomiting, sore throat, joint abnormalities (individual joints
specified) including recurrentjoint abnormalities, neurologic abnormalities, cardiac
abnormalities, other signs and symptoms; a request for results of laboratory tests;
type, dose, and dates of antibiotic therapy and other medication prescribed, date of
physician visit if any, and dates of hospitalization if any.
Case Definition
In this study we adopted and slightly modified a case definition that had been
coordinated by Dr. George Schmid at the Centers for Disease Control in coopera-
tion with other LD investigators. According to this definition, diagnostic categories
were based on the occurrence ofECM and multisystem illness and on thegeographic
area of exposure to ticks. Specifically with regard to multisystem involvement the
following abnormalities were included: (1) cardiovascular: atrioventricular conduc-
tion defects, electrocardiographic evidence ofmyocarditis ormyopericarditis, or left
ventricular dysfunction; (2) neurologic: clinical evidence of meningoencephalitis
(headache and stiff neck), chorea, cerebellar ataxia, cranial or peripheral
neuropathy, ormyelitis; (3)joint: short (lasting at least one day), often recurrent, at-
tacks of migratory polyarthritis or oligoarticular arthritis (swelling and pain). The
case categories included:
1. Confirmed case
A. Exposure in a known endemic area: ECM, with exposure occurring no
more than 30 days prior to onset of the skin lesion; or
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B. No exposure to a known endemic area: ECM and two of the three systems
described under multisystem involvement.
2. Probable case
A. Exposure in a known endemic area: (1) In the absence ofECM, typical in-
volvement of at least two of the three systems as described under
multisystem involvement with exposure occurring no more than 60 days
prior to the onset of involvement of at least one system, or (2) If only one
of the three systems as described in the multisystem involvement has been
involved, then at least one of the following must also be found: (a) history
ofthe tick bite occurring within 60 days prior to the onset of symptoms, or
(b) geographic or family clustering, with at least one illness meeting the
confirmed case definition for LD, or (c) an elevated serum IgM level or
cryoglobulins containing IgM.
B. No exposure to a known endemic area: ECM with involvement of none or
one organ system. Without ECM, there will be no probable cases in a non-
endemic area.
3. Possible case: Any other case reported as LD not meeting the above criteria.
4. Pendingcase: Any non-confirmed casethat cannot be classified as not a case in
which additional information is pending.
5. Not a case: Any case clearly ruled out as being LD.
The definition for an endemic area used in this case definition in Wisconsin com-
prised the geographic region in which Ixodes dammini ticks had been identified
through November 1981. The case definition was used, in part, to evaluate the accu-
racy ofserologic findings in relation to clinical criteria; thus, the case definition did
not include a laboratory criterion for confirmation.
Serologic Testing
Physicians were requested to submit, to the SLH, an acute serum specimen when
available and at least one convalescent serum specimen from each reported patient.
Specimens received at the SLH were stored at -70°C; one ml aliquots were shipped
in batches to the Rocky Mountain Laboratories (RML) in February, August, and
November of 1982. Testing for antibodies to the I. dammini spirochete (Shelter
Island isolate) that causes LD was performed at the RML using the log indirect
immunofluorescent test methods previously described [3,14].
Entomologic Studies
In 1979 we initiated surveys of the distribution of I. dammini and Dermacentor
albipictus in Wisconsin based on tick carriage by white-tailed deer (Odocoileus vir-
ginianus). Surveys completed in 1979 and 1980 were focal in nature, having been
designed to evaluate the density of L dammini in suspected endemic areas and to
collect live ticks in which to search for an etiologic agent of Lyme disease. Surveys
completed in 1981 and 1982 were designed to determine the distribution and relative
density of I. dammini throughout the state. Each of the 1979-82 tick surveys was
conducted on the first two days ofthe deergun-hunting season, always the Saturday
and Sunday preceding Thanksgiving. All ticks in any stage or material suspected of
being a tick were collected from deer that had been killed no more than 24 hours
prior to presentation at the deer kill registration station. Forceps were used to exam-
ine an approximately 300-square-inch area covering the entire right side or left side
of the neck of a deer and extending distally from the ear to the top of the respective
shoulder. The deer were usually examined in the position as presented in a transport
vehicle. In the 1979-80 surveys, the ticks from each deer were placed live into indi-
687vidually labeled screw-cap vials. Ticks from the 1981-82 surveys were placed in indi-
vidually labeled vials containing 70 percent ethyl alcohol. The 1979, 1981, and 1982
collections were shipped to Boston for speciation, staging, and sex determination by
Dr. Spielman. The 1980 collection was shipped to Hamilton, Montana, for similar
identification by Dr. Burgdorfer. For each deer examined, hunters provided the
date, time, and precise location of the deer kill; the sex and the approximate age of
the deer were recorded. The 1979 survey involved two sites in northwestern Wiscon-
sin, and one site each in west central and south central Wisconsin. The 1980 survey
included two sites in northwestern Wisconsin. The 1981 and 1982 surveys included
24 and 11 sites, respectively, widely distributed throughout the state.
While attempts were made to examine at least 50 deer at each site per survey, data
in this report include sites where fewer than 50 deer were evaluated.
All collections at each study site were made by teams ofindividuals trained to use
identical techniques of collection. Teams consisted of two to three individuals; 22
teams participated in the 1981 survey and ten teams participated in the 1982 survey.
RESULTS
Surveillance and Epidemiologic Features
Of 17i reports received for 1980-82, 80 (47 percent) met the case definition for
confirmed LD, 16 (9 percent) for probable LD, 23 (14 percent) for possible LD, 39
(23 percent) were not cases, and 13 (7 percent) were pending. A comparison of 80
confirmed cases to 16 probable cases demonstrated these classifications to be very
similar in demographic and clinical features (Table 1) with the exception of cardiac
abnormalities, which were not observed in any probable case patients. Fourteen of
the 16 probable cases were classified based on the criteria of ECM without a known
exposure to ticks in an endemic area.
The ages of confirmed cases ranged from seven to 77 years with the following dis-
tribution: 0-9 years (4 percent), 10-19 years (14 percent), 20-29 years (18 percent),
30-39 years (18 percent), 40-49 years (16 percent), 50-59 years (15 percent), and 60
or more years (15 percent). Among patients with ECM, approximately 68 percent of
known tick exposures occurred between May 16 and July 15, and approximately
TABLE 1
Erythema Chronicum Migrans/Lyme Disease in Wisconsin:
Demographic Features and Clinical Signs and Symptoms
Among Confirmed and Probable Cases, 1980-1982
Confirmed Probable
Number 80 16
Male (o) 54 (67.5) 12 (75)
Age: Mean (years) 38.7 32.5
Median (years) 37 29
Range (years) 7-77 1-71
ECM (%0) 80 (100) 14 (87.5)
Arthritis (%) 26 (32.5) 6 (37.5)
Arthritis/Arthralgia (%) 55 (68.8) 11 (68.8)
Neurologica (0) 30 (37.5) 4 (25)
Bell's palsy (No) 5 (6.3) 1 (6.3)
Cardiac (o) 6 (7.5) 0 (0)
aHeadache plus stiff neck and/or Bell's palsy
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TABLE 2
Erythema Chronicum Migrans/Lyme Disease in Wisconsin: Antibodies (IFA)
to the I. dammini Spirochete
Case Category pb
Confirmed(C) Prob./Poss. Negative(N)c C vs. N
I. Seroconversion or
fourfold changed 25/41 4/7 0/17 <.001
II. Convalescent antibodyd
(no acute tested) 8/8 2/4 0/1
III. I and lid 33/49 6/11 0/18 <.001
aIndirect immunofluorescent method of Burgdorfer et al. [3]
bFisher's exact text
cNegative = ill controls
dPositive observations/total observations
73 percent of ECM onsets occurred between June 1 and July 31. Among confirmed
cases with known tick bites, the mean interval from tick bite to ECM onset was 9.2
days (median, ten days; range, one to 21 days).
Serologic Tests
Results oftests for antibodies to theL damminispirochete arepresented in Tables
2 and 3. Results oftesting of paired sera and of convalescent sera in the absence of
available acute serum specimens, were available for 78 individuals (Table2). Thirty-
three (67 percent) of 49 confirmed cases as compared to 0 of 18 ill controls had a
demonstrable seroconversion, a fourfold change in antibody titer, or evidence of
antispirochete antibodies in convalescent sera (p < .001, Fisher's exact test). Eval-
uation of only results confined to testing of paired serum demonstrated the same
significant differences. This trend was also noted when probable and possible cases
were compared to non-cases.
TABLE 3
Erythema Chronicum Migrans/Lyme Disease in Wisconsin: The Effect of Penicillin (PEN) or
Tetracycline (TET) Therapy on the Development of Antibodies (IFA)a to the I. dammini Spirochete
in Confirmed Cases
Treatment Categoryb P(Fisher's Exact)
A B C
Early Rx Late Rx No Rx A vs. C A + B vs. C
I. Seroconversion or
fourfold changec 8/18 5/8 16/19 .012 .016
II. Convalescent antibody
(no acute tested)c 2/2
III. I and IIc 8/18 5/8 18/21 .007 .009
"Indirect immunofluorescent method of Burgdorfer et al. [3]
bA. Early treatment = received PEN or TET < 10 days after onset
B. Late treatment = received PEN or TET > 10 days after onset
C. No treatment = did not receive PEN or TET or related antibodies
cPositive observations/total observations
689We evaluated the effects ofpenicillin and tetracycline therapy on the development
of antibodies to spirochetes by comparing results of serologic testing of confirmed
LD patients who received penicillin or tetracycline early (less than ten days after ill-
ness onset) or late (more than ten days after illness onset) to those to whom antibi-
otics were not administered (Table 3). The late therapy data are too small to evaluate
individually. However, 8 (44.4 percent) of 18 patients who received early penicillin
or tetracycline and 13 (50 percent) of 26 patients who received early or late therapy,
developed antibodies to spirochetes as compared to 18 (86 percent) of 21 who re-
ceived no therapy (p = .007 and .009, respectively, Fisher's exact test).
Geographic Distribution of Cases and Entomologic Studies
The case definition used in this study depends on knowledge of exposure to a
known endemic area to categorize cases. The distribution of the confirmed cases by
county of documented or likely tick exposure is depicted in Fig. IA. Such exposures
were noted in 22 counties. The high prevalence of exposure in the northwest portion
of Wisconsin corresponds geographically to the known distribution ofI. dammini
and to the origin of early reports of LD in Wisconsin. The difference in distribution
of county of residence of these same confirmed case patients (Fig. iB) is generally
due to travel to or military training in endemic areas with individual onsets of illness
often noted after return to home. Among confirmed cases, the county of residence
differed from the county of known or likely tick exposure in 26/77 (34 percent)
cases. However, only 16/77 (21 percent) of confirmed cases resided outside of areas
whereI. dammini is currently known to be present in Wisconsin. The counties of
tick exposure in probable or possible cases (Fig. 1C) are more widely geographically
dispersed.
The tick surveys conducted in 1979-82 during the autumn deer-hunting seasons
have defined the distribution of L dammini in Wisconsin and therefore potential
areas for risk of LD in the state. Cumulatively, these surveys have permitted two
types of comparisons. The first is a comparison of acarologic findings at three
widely geographically separated locations in western Wisconsin (Table 4). In this
component, Dermacentor albipictus represents a geographically established tick that
can be found on deer in late autumn and winter and thus can be used for compara-
tive purposes. Generally, from 1979 to 1981 there were increases in the percentage of
deer examined on which one or more L dammini were found, a decrease in the per-
centage of deer with one or more D. albipictus found in any stage, an increase in the
mean number of L dammini per deer, a large increase in the percentage of L dam-
mini among total ticks collected, and a reversal in the ratio ofI. dammini to D. al-
bipictus found in any stage on deer examined. This suggested that the density of
L dammini in western Wisconsin was increasing and that this increase may have
covered a broad geographic area; however, specifically at the west central study
sites, this trend was not noted. A confirming trend was not noted when 1982 survey
data was compared to 1981 data; in fact, we observed a reduction in the density of
L dammini in 1982 in relation to 1981. However, a relative trend was noted to con-
tinue when comparing 1979 data to 1982 data.
The second comparison involved the 1981 and 1982 surveys at observation sites
selected for a statewide representative geographic distribution (Fig. 2). Based on
I. dammini density data, the state could be divided into three regions. The northwest
(regionI) was the region of highest density, the Wisconsin River Valley (regionII)
was the region of intermediateI. dammini density, and the rest of the state (region
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FIG. 1. County oftick exposure and county ofresidence for confirmed, possible, and probable cases of
Lyme disease; Wisconsin, 1980-1982. (above left) A. County of tick exposure for confirmed cases
only; Wisconsin, 1980-1982. (above right) B. County of residence for confirmed cases only; Wis-
consin, 1980-1982. (below) C. County of tick exposure for probable and possible cases only; Wis-
consin, 1980-1982.
TABLE 5
Wisconsin Tick Survey, November 1981 and November 1982: Comparison of Mean Densities
of I. dammini (ID) per Deer by Region Utilizing Geographically Comparable Sites
1981 1982
Regiona No. of Deer Mean ID/Deer (- SD) No. of Deer Mean ID/Deer (+ SD)
I 127 2.32 + 3.51 141 0.58 i 1.61
II 189 0.88 + 3.50 209 0.23 + 0.75
III 121 0.01 + 0.09 134 0.01 + 0.09
aRefer to Fig. 2.
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III
FIG. 2. Wisconsin tick survey, November 1981 and November 1982; distribution of study sites by
region and distribution of counties in which I. dammini has been identified.
III), had a virtual absence of L dammini. While the relative differences in I. dam-
mini densities between regions were the same in 1981 and 1982, the actual density by
region decreased from 1981 to 1982 (Table 5).
DISCUSSION
Lyme disease and its vector have been present in Wisconsin for at least 15 years.
The 1968 case report ofECM inthe grouse hunter in Wisconsin conforms to the case
definition of confirmed LD used in this study. In addition to having ECM, joint,
and neurologic abnormalities, the patient had a history of a tick bite in Taylor
County prior to onset of illness [9]. The northern variety of L scapularis, now re-
classified as L dammini [15], was documented to be present in Taylor County during
0 SITE IN 1981
. SITE IN 1981 and 1982
* COUNTY IN WHICH I. DAMMINI
HAS BEEN IDENTIFIED
693an acarologic study conducted in 1968 [16]. All ticks collected in the 1968 study have
been reclassified as I. dammini [Dr. Andrew Spielman: personal communication].
While both the disease and the vector had been documented in Wisconsin as early as
1968, and were again recognized in 1978, the magnitude of the LD problem in Wis-
consin during the intervening ten years is unknown. In addition to the early recogni-
tion ofL dammini and ECM in Wisconsin, the breadth ofthe area in which L dam-
mini currently can be found in Wisconsin is considerable, approximately 36,240
square miles.
Data presented in this report represents a continuum of LD and acarologic sur-
veillance in Wisconsin at first limited to northwestern and west central Wisconsin
and then expanded to a statewide effort by 1981. All reports ofhuman disease were
obtained by use of a heightened passive surveillance system in which clinicians
were frequently reminded of the condition and apprised of available resources, but
were not called regularly to stimulate new reports ofillness. Inaddition, we screened
reports of clinical illness accompanying specimens to be tested at the SLH for a va-
riety of rash illnesses, and for illnesses suggestive of meningoencephalitis, carditis,
or arthritis. Our series might thus include adisproportionate number ofcomplicated
cases and not be fully representative of LD as it occurs in Wisconsin. However, the
demographic features, seasonal occurrence, and distribution of clinical signs and
symptoms in this series are very similar to those initially reported by Steere and col-
leagues [1,2]. More exhaustive studies of early clinical manifestations of disease
published subsequent to the time that our study was conducted provide a defini-
tive, comprehensive listing and discussion of early signs and symptoms of LD [17].
As stated, the case definition in this study did not include a criterion for labora-
tory confirmation in order to evaluate the accuracy of clinical criteria in relation to
serologic findings. The high rate of development of antibodies to the Shelter Island
isolate of the I. dammini spirochete among confirmed cases and the virtual absence
of antibodies among ill controls who clearly did not have LD, provide additional
data to support the spirochetal etiology of LD. (Much of this study was conducted
prior to reports ofisolation ofthe spirochete from clinical material obtained from LD
patients [4,5] which provide the most compelling and definitive etiologic evidence.)
Some patient sera may have lacked an antibody response for any of several rea-
sons. Spirochete strains present in ticks along the eastern seaboard may show anti-
genic variations from those in Wisconsin. If cross-reactivity between the strains is
indeed incomplete, it is possible that serologic confirmation ofWisconsin LD infec-
tions may be missed by using the Shelter Island antigen. This issue can be resolved
by testing ofpatient sera against aWisconsin-derived spirochete and bycomparative
antibody studies on avariety of(human- and non-human-derived) I. damminispiro-
chete strains obtained from a variety of regions in the United States, Europe, and
elsewhere. Regional differences in I. dammini ticks might be another factor that
could modify spirochete activity and alter infectivity in humans or other mammals.
Differences in microbial symbiotes known to be present in ticks [18] could theo-
retically affect virulence or transmissibility.
Another factor bearing on theantibodyresponseis antibiotictherapy. Steere et al.
have shown that penicillin and tetracycline therapy can significantly shorten the
duration of ECM and its associated symptoms and prevent or attenuate the subse-
quent arthritis [19,20]. Our finding suggesting blunting of the specific antibody
response to the spirochete with early and appropriate antibiotic therapy demon-
strates that serologic diagnosis of LD may be difficult in treated cases. Fortunately,
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ECM is an excellent clinical marker [17]; however, serologic evaluation becomes
more critical in patients where ECM is missed or not present, additional manifesta-
tions of LD persist, and the patient may have received penicillin or tetracycline for
treatment of the illness. The case definition did have proven utility as none of 18
non-case patients serologically evaluated had evidence of antibodies against the
I. dammini spirochete.
The definition of an endemic region in the case definition used in this study was
arbitrarily established as the region inclusive of counties in which I. dammini had
been documented as of November 1981. The distribution of possible and probable
cases in our study reflects the lack of accurate demarcation of the LD endemic re-
gion in the state and the circular nature ofdefining the endemic region based on the
documentation of L dammini in a given county.
Thelocation and identification ofL dammini(I. scapularis, reclassified as L dam-
mini) in six Wisconsin counties in 1968 was thought at that time to be associated
with potholes or depressions resulting from glacial outwash which are common in
the northern lowland forests ofWisconsin [16]. The investigators did not document
any I. dammini in the prairie hardwood forests of southern Wisconsin. If we con-
sider comparable sites oftick collection from 1979 to 1982, the most striking result is
the number of I. dammini identified on deer in 1981 and 1982 as compared with
1979, particularly in southwestern and west central Wisconsin. This, along with the
earlier acarologic observations in Wisconsin, would suggest that I. dammini is
spreading in a southerly direction in Wisconsin. It is interesting to note that al-
though I. dammini ticks have been identified in the southern third of Wisconsin,
particularly in the western part of the state, very few cases of LD have been docu-
mented to originate in that region. The gradient ofincreasing I. damminidensity as
one moves from east to west in the state is notable; however, the ecologic factors
that control this phenomenon have yet tobe determined. It will take additional years
of observation to fully understand the dynamics ofI. dammini distribution and LD
occurrence in Wisconsin.
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